Home > Publications database > miR-137 inhibits melanoma cell proliferation through downregulation of GLO1. > print |
001 | 132559 | ||
005 | 20240229105023.0 | ||
024 | 7 | _ | |a 10.1007/s11427-017-9138-9 |2 doi |
024 | 7 | _ | |a pmid:29307109 |2 pmid |
024 | 7 | _ | |a 1006-9305 |2 ISSN |
024 | 7 | _ | |a 1674-7305 |2 ISSN |
024 | 7 | _ | |a 1862-2798 |2 ISSN |
024 | 7 | _ | |a 1869-1889 |2 ISSN |
024 | 7 | _ | |a altmetric:31401072 |2 altmetric |
037 | _ | _ | |a DKFZ-2018-00237 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Lv, Na |b 0 |
245 | _ | _ | |a miR-137 inhibits melanoma cell proliferation through downregulation of GLO1. |
260 | _ | _ | |a Heidelberg |c 2018 |b Springer37831 |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1663742415_16521 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2018 May;61(5):541-549 |
520 | _ | _ | |a Late-stage melanoma is refractory to current therapies. MicroRNAs (miRNAs) can modulate many physiological and pathological processes of melanoma. Studies have demonstrated that miR-137 acts as a tumor suppressor by inhibiting the proliferation of melanoma cells through targeting multiple mRNAs. The glyoxalase system member glyoxalase 1 (GLO1) is the principal scavenging enzyme of methylglyoxal (MG), a toxic byproduct of glycolysis. Using35S in vivo/vitro labelling analysis for dynamic proteomics (SiLAD), we found that miR-137 downregulated the expression of GLO1 in melanoma cells. Bioinformatics analysis predicted that GLO1 is a direct target of miR-137. This was validated by dual luciferase reporter assay. Quantitative RT-PCR (qRT-PCR) and western blot analysis indicated that miR-137 could decrease endogenous GLO1 expression. Furthermore, siRNA targeting of GLO1 mimicked inhibition of melanoma cell proliferation caused by miR-137 overexpression. Re-expression of GLO1 was able to restore miR-137-mediated suppression of melanoma cell proliferation. Therefore, these results suggest that miR-137 inhibits the proliferation of melanoma cells by targeting GLO1. |
536 | _ | _ | |a 317 - Translational cancer research (POF3-317) |0 G:(DE-HGF)POF3-317 |c POF3-317 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Hao, Shuai |b 1 |
700 | 1 | _ | |a Luo, Chonglin |b 2 |
700 | 1 | _ | |a Abukiwan, Alia |0 P:(DE-He78)ee782484657011f0081a1425afa47a3f |b 3 |u dkfz |
700 | 1 | _ | |a Hao, Ying |b 4 |
700 | 1 | _ | |a Gai, Fei |b 5 |
700 | 1 | _ | |a Huang, Weiwei |b 6 |
700 | 1 | _ | |a Huang, Lingyun |b 7 |
700 | 1 | _ | |a Xiao, Xueyuan |b 8 |
700 | 1 | _ | |a Eichmüller, Stefan |0 P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944 |b 9 |u dkfz |
700 | 1 | _ | |a He, Dacheng |b 10 |
773 | _ | _ | |a 10.1007/s11427-017-9138-9 |0 PERI:(DE-600)2133225-3 |n 5 |p 541-549 |t Science in China / C |v 61 |y 2018 |x 1869-1889 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:132559 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)ee782484657011f0081a1425afa47a3f |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-317 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Translational cancer research |x 0 |
914 | 1 | _ | |y 2018 |
915 | _ | _ | |a Allianz-Lizenz / DFG |0 StatID:(DE-HGF)0400 |2 StatID |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SCI CHINA LIFE SCI : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
920 | 1 | _ | |0 I:(DE-He78)G182-20160331 |k G182 |l GMP Einheit Zelluläre Therapie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)G182-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|